CY1120103T1 - Κλιμακωσιμο συστημα παραγωγης λεντιικου φορεα, συμβατο με βιομηχανικες φαρμακευτικες εφαρμογες - Google Patents
Κλιμακωσιμο συστημα παραγωγης λεντιικου φορεα, συμβατο με βιομηχανικες φαρμακευτικες εφαρμογεςInfo
- Publication number
- CY1120103T1 CY1120103T1 CY20181100358T CY181100358T CY1120103T1 CY 1120103 T1 CY1120103 T1 CY 1120103T1 CY 20181100358 T CY20181100358 T CY 20181100358T CY 181100358 T CY181100358 T CY 181100358T CY 1120103 T1 CY1120103 T1 CY 1120103T1
- Authority
- CY
- Cyprus
- Prior art keywords
- care
- length
- pharmaceutical applications
- scale system
- system compatible
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αφορά την εκβιομηχάνιση της παραγωγής ανασυνδυασμένων λεντιικών φορέων ώστε να παρασκευαστούν επαρκή υλικά για θεραπευτικές εφαρμογές, όπως η γονιδιακή θεραπεία και/ή ο εμβολιασμός DNA, για χρήση σε κλινικές δοκιμές και/ή εμπορική χρήση.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161563566P | 2011-11-24 | 2011-11-24 | |
EP11306551 | 2011-11-24 | ||
PCT/EP2012/073645 WO2013076309A1 (en) | 2011-11-24 | 2012-11-26 | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
EP12795778.5A EP2782997B1 (en) | 2011-11-24 | 2012-11-26 | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1120103T1 true CY1120103T1 (el) | 2018-12-12 |
Family
ID=48469165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20181100358T CY1120103T1 (el) | 2011-11-24 | 2018-03-30 | Κλιμακωσιμο συστημα παραγωγης λεντιικου φορεα, συμβατο με βιομηχανικες φαρμακευτικες εφαρμογες |
Country Status (19)
Country | Link |
---|---|
US (3) | US20140315294A1 (el) |
EP (2) | EP2782997B1 (el) |
JP (2) | JP6280869B2 (el) |
CN (2) | CN104136605B (el) |
AU (1) | AU2012342355B2 (el) |
BR (1) | BR112014012600A2 (el) |
CA (1) | CA2856455C (el) |
CY (1) | CY1120103T1 (el) |
DK (1) | DK2782997T3 (el) |
ES (1) | ES2663815T3 (el) |
HR (1) | HRP20180424T1 (el) |
HU (1) | HUE036742T2 (el) |
LT (1) | LT2782997T (el) |
PL (1) | PL2782997T3 (el) |
PT (1) | PT2782997T (el) |
RS (1) | RS57066B1 (el) |
SG (1) | SG11201402584RA (el) |
SI (1) | SI2782997T1 (el) |
WO (1) | WO2013076309A1 (el) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013076309A1 (en) * | 2011-11-24 | 2013-05-30 | Genethon | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
FR3010720B1 (fr) | 2013-09-16 | 2017-08-11 | Genethon | Procede de production de virus enveloppes |
FR3014901B1 (fr) | 2013-12-17 | 2017-06-09 | Genethon | Procede de purification de virus ou vecteurs viraux enveloppes |
US10538785B2 (en) | 2013-12-23 | 2020-01-21 | Renaud Vaillant | Lyophilized lentiviral vector particles, compositions and methods |
GB201417042D0 (en) * | 2014-09-29 | 2014-11-12 | Fkd Therapies Oy | Method |
EP4316500A3 (en) | 2015-05-13 | 2024-04-10 | CSL Behring Gene Therapy, Inc. | Bio-production of lentiviral vectors |
CN105483092A (zh) * | 2015-10-10 | 2016-04-13 | 和元生物技术(上海)股份有限公司 | 一种中试化生产重组腺相关病毒的新技术 |
JP2019509275A (ja) | 2016-02-23 | 2019-04-04 | イミューン デザイン コーポレイション | マルチゲノムレトロウイルスベクター調製物ならびにそれらを産生および使用するための方法およびシステム |
KR102535013B1 (ko) * | 2016-04-14 | 2023-05-22 | 트리젤 엘티디. | 정유량 펌프/튜빙 시스템이 있는 고정층 바이오 리액터 |
KR102581578B1 (ko) * | 2016-09-30 | 2023-09-25 | 라이프 테크놀로지스 코포레이션 | 렌티바이러스 생산을 위한 무-혈청 현탁 시스템 |
CN106867877A (zh) * | 2017-02-15 | 2017-06-20 | 昆明医科大学第二附属医院 | 一种密闭式慢病毒载体培养装置和培养方法 |
US11674115B2 (en) | 2017-10-31 | 2023-06-13 | Global Life Sciences Solutions Usa Llc | Flexible bag |
CN111727251A (zh) | 2017-11-21 | 2020-09-29 | 克里斯珀医疗股份公司 | 用于治疗常染色体显性色素性视网膜炎的材料和方法 |
WO2019123430A1 (en) | 2017-12-21 | 2019-06-27 | Casebia Therapeutics Llp | Materials and methods for treatment of usher syndrome type 2a and/or non-syndromic autosomal recessive retinitis pigmentosa (arrp) |
CA3084632A1 (en) | 2017-12-21 | 2019-06-27 | Crispr Therapeutics Ag | Materials and methods for treatment of usher syndrome type 2a |
CN110317791A (zh) * | 2018-03-29 | 2019-10-11 | 西比曼生物科技(香港)有限公司 | Gmp级无血清悬浮细胞大规模生产慢病毒的方法 |
CN108866013B (zh) * | 2018-08-06 | 2021-03-23 | 武汉赛科成科技有限公司 | 一种大规模生产慢病毒的方法 |
US20210348192A1 (en) * | 2018-09-20 | 2021-11-11 | National University Corporation Tokyo Medical And Dental University | Method for increasing lentiviral vector production |
CN109401969B (zh) * | 2018-12-13 | 2024-02-02 | 珠海西格膜生物技术有限公司 | 一种细胞工厂的管道连接系统及其使用方法 |
JP7333930B2 (ja) * | 2019-01-07 | 2023-08-28 | 独立行政法人国立高等専門学校機構 | ミミズ細胞の保存方法及びミミズ培養細胞の形質転換方法 |
CN113122501B (zh) * | 2019-12-30 | 2023-06-16 | 重庆精准生物技术有限公司 | 适合大规模临床级病毒载体制备的培养基及其应用 |
WO2021242785A1 (en) * | 2020-05-26 | 2021-12-02 | Expression Therapeutics, Llc | Lentiviral system |
WO2022143623A1 (zh) * | 2020-12-29 | 2022-07-07 | 江苏金斯瑞蓬勃生物科技有限公司 | 高分散性的hek293t细胞株及其筛选方法 |
GB202100688D0 (en) * | 2021-01-19 | 2021-03-03 | Autolus Ltd | Process |
WO2023061409A1 (zh) * | 2021-10-12 | 2023-04-20 | 江苏金斯瑞蓬勃生物科技有限公司 | 适应无血清悬浮培养的hek293细胞株及其应用 |
WO2023069998A1 (en) * | 2021-10-19 | 2023-04-27 | Amgen Inc. | Composition and methods for recombinant lentiviral production |
WO2023200679A1 (en) * | 2022-04-11 | 2023-10-19 | Adverum Biotechnologies, Inc. | OPTIMIZATION OF HEK293 SUSPENSION PLATFORM FOR IMPROVED rAAV TITERS |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2722506B1 (fr) | 1994-07-13 | 1996-08-14 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucleiques, preparation et utilisations |
US6210922B1 (en) | 1998-11-30 | 2001-04-03 | National Research Council Of Canada | Serum free production of recombinant proteins and adenoviral vectors |
US20030096414A1 (en) | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
WO2003039459A2 (en) * | 2001-11-05 | 2003-05-15 | Genvec, Inc. | Viral vector production methods and compositions |
GB0702695D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
PL2307551T3 (pl) | 2008-06-18 | 2017-07-31 | Oxford Biomedica (Uk) Limited | Oczyszczanie wektorów retrowirusowych |
US20110008894A1 (en) | 2009-07-07 | 2011-01-13 | Cayla | Lyophilized plasmid/dna transfection reagent carrier complex |
US8580554B2 (en) | 2009-07-31 | 2013-11-12 | Baxter International Inc. | Method of producing a polypeptide or virus of interest in a continuous cell culture |
WO2011097447A2 (en) * | 2010-02-04 | 2011-08-11 | Neurologix, Inc. | Production of recombinant virus |
MX2013007551A (es) | 2011-01-05 | 2013-10-30 | Expression Therapeutics Llc | Metodo y sistema para suspension de cultivo celular. |
WO2013076309A1 (en) * | 2011-11-24 | 2013-05-30 | Genethon | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
-
2012
- 2012-11-26 WO PCT/EP2012/073645 patent/WO2013076309A1/en active Application Filing
- 2012-11-26 EP EP12795778.5A patent/EP2782997B1/en not_active Revoked
- 2012-11-26 CN CN201280058157.9A patent/CN104136605B/zh active Active
- 2012-11-26 HU HUE12795778A patent/HUE036742T2/hu unknown
- 2012-11-26 JP JP2014542880A patent/JP6280869B2/ja active Active
- 2012-11-26 DK DK12795778.5T patent/DK2782997T3/en active
- 2012-11-26 LT LTEP12795778.5T patent/LT2782997T/lt unknown
- 2012-11-26 EP EP17210574.4A patent/EP3327119A1/en not_active Withdrawn
- 2012-11-26 ES ES12795778.5T patent/ES2663815T3/es active Active
- 2012-11-26 PT PT127957785T patent/PT2782997T/pt unknown
- 2012-11-26 CA CA2856455A patent/CA2856455C/en active Active
- 2012-11-26 RS RS20180365A patent/RS57066B1/sr unknown
- 2012-11-26 US US14/359,960 patent/US20140315294A1/en not_active Abandoned
- 2012-11-26 SI SI201231258T patent/SI2782997T1/en unknown
- 2012-11-26 AU AU2012342355A patent/AU2012342355B2/en not_active Ceased
- 2012-11-26 PL PL12795778T patent/PL2782997T3/pl unknown
- 2012-11-26 SG SG11201402584RA patent/SG11201402584RA/en unknown
- 2012-11-26 BR BR112014012600A patent/BR112014012600A2/pt not_active Application Discontinuation
- 2012-11-26 CN CN201810811238.0A patent/CN109097398A/zh active Pending
-
2017
- 2017-10-05 JP JP2017195148A patent/JP2018046828A/ja active Pending
-
2018
- 2018-03-12 HR HRP20180424TT patent/HRP20180424T1/hr unknown
- 2018-03-30 CY CY20181100358T patent/CY1120103T1/el unknown
-
2019
- 2019-03-18 US US16/356,005 patent/US20190211360A1/en not_active Abandoned
-
2021
- 2021-09-02 US US17/464,727 patent/US20220235371A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220235371A1 (en) | 2022-07-28 |
JP2014533516A (ja) | 2014-12-15 |
US20140315294A1 (en) | 2014-10-23 |
WO2013076309A1 (en) | 2013-05-30 |
AU2012342355B2 (en) | 2017-10-12 |
EP2782997B1 (en) | 2018-01-10 |
CA2856455A1 (en) | 2013-05-30 |
HUE036742T2 (hu) | 2018-07-30 |
ES2663815T3 (es) | 2018-04-17 |
SI2782997T1 (en) | 2018-04-30 |
LT2782997T (lt) | 2018-05-25 |
HRP20180424T1 (hr) | 2018-06-29 |
RS57066B1 (sr) | 2018-06-29 |
CA2856455C (en) | 2022-08-23 |
PL2782997T3 (pl) | 2018-06-29 |
DK2782997T3 (en) | 2018-04-16 |
JP6280869B2 (ja) | 2018-02-14 |
CN104136605A (zh) | 2014-11-05 |
CN104136605B (zh) | 2018-08-14 |
JP2018046828A (ja) | 2018-03-29 |
EP2782997A1 (en) | 2014-10-01 |
SG11201402584RA (en) | 2014-06-27 |
AU2012342355A1 (en) | 2014-07-17 |
PT2782997T (pt) | 2018-04-09 |
EP3327119A1 (en) | 2018-05-30 |
CN109097398A (zh) | 2018-12-28 |
BR112014012600A2 (pt) | 2017-06-06 |
US20190211360A1 (en) | 2019-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120103T1 (el) | Κλιμακωσιμο συστημα παραγωγης λεντιικου φορεα, συμβατο με βιομηχανικες φαρμακευτικες εφαρμογες | |
CY1121934T1 (el) | Αντισωματα anti-fcrn | |
CY1123142T1 (el) | Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων | |
CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
CY1121511T1 (el) | Ενωσεις και μεθοδοι για διαμορφωση κινασων και ενδειξεις αυτων | |
CY1120421T1 (el) | Ενωσεις και μεθοδοι για διαμορφωση κινασων και ενδειξεις αυτων | |
CY1120471T1 (el) | Αντισωματα κατα του cd70 | |
CY1119200T1 (el) | Νεα παραγωγα βενζιμιδαζολιου ως ερ4 ανταγωνιστες | |
CY1120390T1 (el) | Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων | |
CR20150258A (es) | Anticuerpos anti-ceacam5 y usos de éstos | |
CY1117372T1 (el) | Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους | |
CY1119055T1 (el) | Αντισωματα που προσδενονται στην il-17a και στην il-17f | |
CY1116100T1 (el) | Παραγωγα πυριμιδινονης, η παρασκευη τους και η φαρμακευτικη τους χρηση | |
CY1121466T1 (el) | Αντισωματα εναντι προσδεματων υποδοχεα β1 βραδυκινινης | |
CY1118900T1 (el) | Δικυκλικως υποκατεστημενες ουρακιλες και η χρηση αυτων | |
PH12018500826B1 (en) | Extracorporeal life support system and methods of use thereof | |
BR112014027852A2 (pt) | recipientes flexíveis com múltiplos volumes de produto | |
UY34885A (es) | Proteínas de unión anti-mesotelina | |
UY34254A (es) | Proteínas y péptidos modificados. | |
BR112014011404A2 (pt) | moléculas de anticorpos com especificidade para o ox40 humano | |
EA201500172A1 (ru) | Модифицированные полипептиды фактора х и их применение | |
CL2014002846A1 (es) | Usos terapéuticos de proteínas del factor de crecimiento del fibroblasto 21. | |
BR112014002817A2 (pt) | Uso de um polipeptídeo p62, ou de um ácido nucleico que codifica p62 | |
EA201590359A1 (ru) | Лечение ревматоидного артрита | |
UY34663A (es) | Acido nucleico y proteina recombinante del gen de la endotoxina axmi345, vectores, células, composiciones y métodos para proteger plantas |